The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 25, 2019

Filed:

Aug. 19, 2016
Applicant:

Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);

Inventors:

Jeffrey D. Lee, New York, NY (US);

Wojtek Auerbach, Ridgewood, NJ (US);

David Heslin, Closter, NJ (US);

David Frendewey, New York, NY (US);

Ka-Man Venus Lai, Tarrytown, NY (US);

David M. Valenzuela, Yorktown Heights, NY (US);

Assignee:

Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A01K 67/02 (2006.01); A61D 19/04 (2006.01); C12N 15/85 (2006.01); A01K 67/027 (2006.01); C12N 15/877 (2010.01); C12N 5/0735 (2010.01);
U.S. Cl.
CPC ...
C12N 15/8509 (2013.01); A01K 67/02 (2013.01); A01K 67/0271 (2013.01); A01K 67/0275 (2013.01); A61D 19/04 (2013.01); C12N 5/0606 (2013.01); C12N 15/8775 (2013.01); A01K 2207/12 (2013.01); A01K 2217/15 (2013.01); A01K 2227/105 (2013.01); C12N 2501/235 (2013.01); C12N 2501/727 (2013.01); C12N 2501/999 (2013.01); C12N 2510/00 (2013.01);
Abstract

Compositions and methods are provided for making rat pluripotent and totipotent cells, including rat embryonic stem (ES) cells. Compositions and methods for improving efficiency or frequency of germline transmission of genetic modifications in rats are provided. Such methods and compositions comprise an in vitro culture comprising a feeder cell layer and a population of rat ES cells or a rat ES cell line, wherein the in vitro culture conditions maintain pluripotency of the ES cell and comprises a media having mouse leukemia inhibitory factor (LIF) or an active variant or fragment thereof. Various methods of establishing such rat ES cell lines are further provided. Methods of selecting genetically modified rat ES cells are also provided, along with various methods to generate a transgenic rat from the genetically modified rat ES cells provided herein. Various kits and articles of manufacture are further provided.


Find Patent Forward Citations

Loading…